MicroPort Scientific Corporation (MCRPF)
OTCMKTS · Delayed Price · Currency is USD
1.570
0.00 (0.00%)
Feb 10, 2026, 9:30 AM EST
MicroPort Scientific Revenue
MicroPort Scientific had revenue of $547.53M in the half year ending June 30, 2025, with 13.45% growth. This brings the company's revenue in the last twelve months to $1.02B, down -0.67% year-over-year. In the year 2024, MicroPort Scientific had annual revenue of $1.03B with 8.45% growth.
Revenue (ttm)
1.02B
Revenue Growth
-0.67%
P/S Ratio
2.60
Revenue / Employee
162.22K
Employees
6,287
Market Cap
2.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.03B | 80.34M | 8.45% |
| Dec 31, 2023 | 950.73M | 109.89M | 13.07% |
| Dec 31, 2022 | 840.83M | 62.19M | 7.99% |
| Dec 31, 2021 | 778.64M | 129.91M | 20.02% |
| Dec 31, 2020 | 648.73M | -144.76M | -18.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
MicroPort Scientific News
- 5 months ago - MicroPort Scientific Corp (MCRPF) (H1 2025) Earnings Call Highlights: Navigating Challenges ... - GuruFocus
- 5 months ago - Half Year 2025 Microport Scientific Corp Earnings Call (Chinese, English) Transcript - GuruFocus
- 1 year ago - Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific - BNN Bloomberg